Swiss startup Caeli Nova raises CHF 8 million funding to deliver its new emergency oxygen system onto passenger aircraft
This latest round of investment will allow the breathing technology developer to take greater strides in enhancing its technology, and to bring its first products to the market.
The largest innovation enabler in the world, Plug and Play, announced the launch of a new office in Basel, Switzerland, in partnership with the first Founding Partner, uptownBasel.
Crypto Valley Venture Capital initiates investment strategy to build blockchain accelerator for African startups
African blockchain disruptors and early-stage startups have joined CV Labs Global Incubation Program Batch 03. The African contingent of incubatees is reflective of Crypto Valley Venture Capital’s (CV VC) global investment strategy.
Israeli logistics AI startup Amphorica partners with Swiss investor Falco Capital to accelerate growth
Falco Capital and Amphorica jointly announced the closing of a capital investment and cooperation agreement. As part of the agreement, Amphorica appoints Falco Capital partner Peter Salzer, as Director of the company's board.
DayOne, the healthcare innovation initiative based in Switzerland, announced the extended deadline for the global call for its digital health accelerator to Friday, 5 November 2021.
Some of the services it offers include trade routing, price aggregation, AI based market analysis and reporting solutions.
[Startup Interview] PJF Schmidt, Lucas Brosi, Marcus Luer, Urs Meier, Founders, Heroes AG, Switzerland
Heroes AG is a Swiss startup that has tapped into the underdeveloped fan merchandising sector through distribution of modern and trendy lifestyle products.
Vaionex Corporation, a blockchain startup founded by students from the University of Cambridge, announced it has completed a seed funding round with Two Hop Ventures, a Dutch venture capital firm focused exclusively on investing in Bitcoin SV startup.
MindMed partners with Swiss psychedelic drug discovery startup MindShift Compounds to patent next-gen psychedelic compounds
MindMed, a psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties.
Swiss biotech startup Memo Therapeutics raises €13.9m to support clinical development of potent antibodies
Swiss biotech startup Memo Therapeutics AG, an innovator in the field of antibody discovery and immune repertoire analysis, announced it has raised €13.9 million in Series B financing.
TEAL, the smart blockchain ecosystem, is partnering with CorionX, the Corion Foundation that supports stablecoin and DeFi awareness through its #MoneyInTheRightDirectionMovement.
Swiss healthtech startup Mobile Health AG selects Infosys for its commercial launch of Consilium Care
Infosys, next-generation digital services and consulting company has been selected by Mobile Health AG to enhance the go-to-market (GTM) strategy for its electronically patient-reported outcomes (ePRO) platform, Consilium Care™.
Switzerland's telecommunications and IT company Swisscom is joining forces with Ericsson and Qualcomm CDMA Technologies GmbH to identify the world's most innovative startups and research teams working on 5G applications.
turicode, a successful Software-as-a-Service provider in the field of document processing solutions based on machine learning and deep learning raised €2 million seed investments to fund the company’s growth plans.
Olympe, a disruptive software development platform for large companies announced the closing of €2.3 million funding round.
Swiss cleantech stratup Insolight announced that a Series A Round of €4.6 million has successfully been closed led by Investiere, with co-investors Zürcher Kantonalbank, Swiss Immo Lab and a number of private business angels.
Advertima, an emerging computer vision platform provider, announced the close of a €15 million Series A investment round led by existing shareholder Swiss real estate company, Fortimo Group.
CUTISS AG, an innovative Swiss Life Science Company has successfully closed its series B financing round at €18.7 million, which was eventually oversubscribed.
Swiss digital financial services company, Alpian SA, has announced a successful Series A funding round worth CHF 12.2 million, approximately €11.5 million.